Academy Discourse: 'Risk regulation, uncertainty and ethics in governing biotechnologies' Professor Joyce Tait CBE, University of Edinburgh
WhenTuesday, November 10, 2015, 18:00
This Discourse will consider how life science innovation trajectories are affected by our governance systems and the perspectives of different stakeholder groups. These factors will determine what new products and processes are able to reach a market place, which industry sectors thrive and which are driven out of business, the relative roles of small and large companies, and the competitive advantage of regions and nations in the global bio-economy. Some suggestions will be offered on how we can improve our management of these complex interactions.
Professor Joyce Tait, CBE is the Director of the Innogen Institute, and a professor at the University of Edinburgh. She has an interdisciplinary background in natural and social sciences, covering agrochemical, pharmaceutical and life science industry sectors, focusing on: strategic planning for innovation; governance, risk management and regulation; and stakeholder attitudes and influences. Relevant life science areas include synthetic biology, genetic databases, GM crops, biofuels, pharmaceuticals, stem cell therapies, stratified and translational medicine.
She is a Fellow of the Royal Society of Edinburgh and also of the Society for Risk Analysis. Current and recent appointments include: John Innes Centre Science and Impact Advisory Board; UK Department for Business Innovation and Skills (BIS) Synthetic Biology Leadership Council (also Chair of its Governance Subgroup); UK Department of Health Emerging Science and Bioethics Advisory Committee (ESBAC); Board of Directors, Roslin Foundation; Scottish Science Advisory Council; Scientific and Technical Council of the International Risk Governance Council, Geneva.
Support the future of sciences & humanities in IrelandMake a donation